ホームページへ
820К+ 2014年以降患者がサポートを受けています
50
1,500 クリニック
6K+ レビュー
3K+ 3,000名以上の資格を持つ医師

ギリシャでの再生不良性貧血診断・治療費用について今すぐご確認ください

料金はお問い合わせください
ギリシャトルコオーストリア
骨髄移植術-から $36,000から $140,000
非血縁者間同種骨髄移植術-から $80,000から $180,000
同種骨髄移植術-から $65,000から $150,000
データは2026年July月時点でBookimedにより検証され、世界70件のクリニックからの患者リクエストと公式見積もりに基づいています。中央値費用は実際の請求書(2024年-2026年)に基づいており毎月更新されます。実際の価格は異なる場合があります。

Bookimedでのお客様のメリットと保証

直接価格

Bookimedは再生不良性貧血治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。

検証済みクリニック・医師のみ

Bookimedはお客様の安全に取り組んでいます。再生不良性貧血治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。

無料24時間365日サポート

Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。再生不良性貧血治療の旅路でお一人になることはありません。

なぜ当社を?

Bookimed専属アシスタント

  • すべての段階でサポート
  • 適切なクリニックと医師の選択をサポート
  • 迅速で便利な情報アクセスを確保

ギリシャの最高の再生不良性貧血クリニックをご発見ください:1件の認証済み選択肢と料金

クリニックはBookimedのスマートシステムにより、5つの主要基準でのデータサイエンス分析を使用してランク付けされています。

このコンテンツを共有

Bookimed患者のビデオストーリー

Dayana
I combined my vacation in Antalya with a check-up.
治療: 女性検査
クリニック: Memorial Antalya Hospital
Igor
It was great! Transfers, accommodation, treatment—all included.
治療: 歯科インプラント
クリニック: WestDent Clinic
Marina
Bookimed did everything for me. I didn't have to worry about anything.
治療: 女性検査
クリニック: Severance Hospital
更新済み: 05/27/2022
著者
アンナ・レオノヴァ
アンナ・レオノヴァ
コンテンツマーケティングチーム責任者
10年以上の経験を持つ認定医療ライターで、文学修士号を持ち、世界中の医療専門家のインタビューに基づくBookimedの信頼できるコンテンツを開発しています。
Fahad Mawlood
医学編集者・データサイエンティスト
一般開業医。4つの科学賞受賞。西アジアでの勤務経験。アラビア語を話す患者様をサポートする医療チームの元チームリーダー。現在はデータ処理と医療コンテンツの正確性を担当
Fahad Mawlood Linkedin
このページは、さまざまな国で利用可能な各種医療状態、治療、ヘルスケアサービスに関する情報を掲載する場合があります。コンテンツは情報提供のみを目的として提供されており、医療アドバイスやガイダンスとして解釈されるべきではないことをご承知おきください。医療治療を開始または変更する前に、医師または資格のある医療専門家にご相談ください。

ギリシャでの再生不良性貧血治療に関するFAQ

これらのFAQはBookimedを通じて医療支援を求める実際の患者からのものです。回答は経験豊富な医療コーディネーターと信頼できるクリニック代表者が行います。

What are the primary treatment options available in Greece for aplastic anemia?

Primary treatment for aplastic anemia in Greece includes immunosuppressive therapy and hematopoietic stem cell transplantation. Medical centers follow international protocols using antithymocyte globulin and cyclosporine. Advanced cases may utilize triple therapy with Eltrombopag. Centers like Interbalkan European Medical Center provide hematological care.

  • Stem cell transplant: Preferred for patients under 40 with matched donors.
  • Immunosuppressive therapy: Standard for older patients using ATG and cyclosporine.
  • Triple therapy protocol: Adding Eltrombopag can accelerate blood cell count recovery.
  • Supportive care: Includes blood transfusions and antimicrobial prophylaxis to prevent infections.

Bookimed Expert Insight: Quality indicators for Greek hematology treatments are verified through international bodies. Interbalkan European Medical Center holds Global Healthcare Accreditation. It also maintains a partnership with Harvard University. These credentials ensure protocols align with top-tier global standards. This is vital for complex bone marrow procedures.

Patient Consensus: Patients note that public hospitals offer free care for EU citizens. However, they emphasize that private facilities often provide faster access to specialized cycles. Many recommend verifying the inclusion of supportive medications in private treatment plans.

Where are the leading centers for aplastic anemia / bone-marrow transplantation in Greece?

Leading centers for aplastic anemia and bone marrow transplantation in Greece include the JACIE-accredited George Papanikolaou General Hospital and the JCI-accredited Interbalkan European Medical Center. These facilities in Athens and Thessaloniki provide specialized care through multidisciplinary teams and international clinical collaborations.

  • George Papanikolaou Hospital: Largest transplant unit in Greece with full JACIE international accreditation.
  • Interbalkan Medical Center: JCI-accredited private facility collaborating with Massachusetts General Hospital.
  • Agia Sophia Children’s Hospital: Primary pediatric reference center collaborating with Johns Hopkins University.
  • Evangelismos General Hospital: Major Athens center recently renovated for advanced hematopoietic therapies.

Bookimed Expert Insight: While public university hospitals handle high patient volumes, private centers like Interbalkan European Medical Center offer distinct advantages for international coordination. This facility holds both Global Healthcare Accreditation and Temos International Healthcare Accreditation. These specific certifications confirm the clinic meets strict global standards for managing medical tourists. Many patients overlook these administrative quality markers when choosing a transplant site.

Patient Consensus: Patients often praise Agia Sophia for pediatric care despite limited national resources. Many advise verifying that a center performs at least 50 transplants annually to ensure optimal expertise.

Is a bone-marrow transplant suitable for every patient with aplastic anemia?

Bone marrow transplant is not suitable for every patient with aplastic anemia. It is generally reserved for severe or very severe cases. Eligibility depends on age, donor availability, and overall health status. Patients under 40 with a matched sibling donor are the strongest candidates for this procedure.

  • Age criteria: Patients under 40 often achieve higher success rates with fewer complications.
  • Donor matching: A perfectly matched sibling donor remains the clinical gold standard for transplants.
  • Disease severity: Transplants are typically prioritized for severe (SAA) or very severe (VSAA) cases.
  • Health status: Candidates must tolerate intensive conditioning involving chemotherapy or radiation before the transplant.

Bookimed Expert Insight: Greek facilities like Interbalkan European Medical Center hold Global Healthcare Accreditation (GHA). This certification specifically evaluates how hospitals manage international patient safety and logistics. For patients over 40, centers often prioritize immunosuppressive therapy over transplants. This approach helps avoid the increased risks of graft-versus-host disease seen in older groups.

Patient Consensus: Patients emphasize the importance of early HLA typing for all family members. Many recommend prioritizing immunosuppressive therapy if a sibling match is not available to avoid transplant complications.

What are the primary treatment options for Severe Aplastic Anaemia in Greece?

Greek haematology centres treat severe aplastic anaemia using stem cell transplants and immunosuppressive therapy. Specialists follow protocols set by the EBMT (European Society for Blood and Marrow Transplantation). Treatment depends on patient age and donor availability. Key facilities are located in Athens and Thessaloniki.

  • Stem cell transplant: First choice for patients under 50 with a matched sibling donor.
  • Immunosuppressive therapy: Uses Antithymocyte Globulin (ATG) and Cyclosporine A for those without donors.
  • Drug enhancement: Haematologists often add Eltrombopag to standard therapy to improve blood counts.
  • Supportive care: Includes regular blood transfusions and medications to prevent fungal or bacterial infections.

Bookimed Expert Insight: Greek medical centres like Interbalkan European Medical Center in Thessaloniki maintain strong international ties. This facility cooperates with Harvard University and Massachusetts General Hospital. Such partnerships mean Greek haematology units apply clinical standards used by leading American university hospitals.

Patient Consensus: Patients find that major Greek hospitals offer a high standard of clinical care. They value centres with GHA accreditation. These facilities provide dedicated support for international medical records and logistics.

Where are the best centres for Aplastic Anaemia treatment in Greece?

Top Greek centres for aplastic anaemia treatment are in Athens and Thessaloniki. Leading units specialise in bone marrow transplantation and immunosuppressive therapy. These facilities often hold Global Healthcare Accreditation (GHA). They manage complex blood disorders using related and unrelated donor transplants.

  • Athens facilities: Laiko General and Attikon University hospitals lead bone marrow investigations.
  • Thessaloniki specialty: George Papanikolaou General Hospital maintains a premier haematopoietic stem cell unit.
  • Private options: Metropolitan General in Athens offers autologous transplants for hypoplastic cases.
  • Clinical standards: Interbalkan European Medical Center holds Temos accreditation for international patient care.

Bookimed Expert Insight: Interbalkan European Medical Center in Thessaloniki partners with Massachusetts General Hospital in the USA. This link provides access to American-standard haematology protocols within the Greek private system. This is a significant advantage for patients seeking a multidisciplinary approach across 36 departments.

Patient Consensus: Patients note that private hospitals in Athens and Thessaloniki offer more flexible visitation. They often highlight the rigorous infection precautions required during bone marrow recovery in Greece.

What are the common side effects of Aplastic Anaemia treatment in Greece?

Treatment in Greece typically involves immunosuppression or bone marrow transplants. Common side effects include serum sickness, marked by fever and rash, and temporary blood count drops. Long-term medication can affect kidney function or blood pressure. Greek clinics provide intensive monitoring to manage these risks.

  • Serum sickness: Causes joint pain and fever 6–18 days after ATG therapy.
  • Blood count drops: Patients may require extra transfusions as counts temporarily decrease.
  • Renal function: Cyclosporine use affects creatinine levels in nearly 40% of cases.
  • Physical changes: Side effects can include gum thickening or increased hair growth.
  • Infection risk: High vulnerability to bacteria and fungi occurs during the first months.

Bookimed Expert Insight: Greek centres like Interbalkan European Medical Center have partnerships with US institutions like Harvard University. This collaboration gives patients access to European protocols. Specialists manage complex reactions using international standards. Such academic ties often lead to better management of acute infusion reactions in Thessaloniki.

Patient Consensus: Patients note that frequent blood tests and fatigue are the most disruptive daily realities. Those having transplants in Greece describe a tough recovery with mouth sores. However, they feel supported by steady infection monitoring.

What questions should I ask a specialist when seeking Aplastic Anaemia treatment in Greece?

Patients should ask about their severity classification to see if immunosuppressive therapy or a transplant is appropriate. Specialists in Greece can clarify donor matching protocols for allogeneic transplants. Essential questions cover infection prevention and blood product safety. Patients should also discuss coordination with Australian haematologists for long-term monitoring.

  • Treatment eligibility: Ask if age or fitness levels favour a transplant or immunosuppressive therapy.
  • Donor matching: Enquire about the process for identifying sibling, unrelated, or haploidentical donors.
  • Supportive care: Confirm the facility provides irradiated and leukocyte-reduced blood products during treatment.
  • Infection protocols: Verify specific prophylactic strategies and emergency plans for fever or infections.
  • Care coordination: Ask how the Greek specialist will communicate results to doctors in Australia.

Bookimed Expert Insight: Greek centres like Interbalkan European Medical Center in Thessaloniki hold Global Healthcare Accreditation. Their cooperation with Massachusetts General Hospital gives Greek specialists access to international protocols for bone marrow failures. Patients should verify if a clinic has dedicated isolation beds. These beds significantly improve recovery safety during intensive therapy.

Patient Consensus: Patients say it is important to confirm which tests distinguish aplastic anaemia from other conditions. They also suggest discussing fertility preservation and iron overload monitoring before starting long-term transfusion support.

How long does it take for Aplastic Anaemia treatment in Greece to show results?

Aplastic anaemia treatment in Greece typically shows initial results at the 3-month mark. Most Greek clinics follow international protocols using immunosuppressive therapy. Success rates for these regimens range between 60% and 85%. Comprehensive results are usually assessed around 6 months.

  • Three-month milestone: Doctors look for improved blood counts or fewer transfusions.
  • Six-month assessment: Patients often achieve transfusion independence or full remission.
  • Success rates: Newer protocols reported in Greek centres reach 80% to 94%.
  • Long-term monitoring: Recovery may continue for months for bone marrow stability.

Bookimed Expert Insight: Greek centres like Interbalkan European Medical Center hold Global Healthcare Accreditation (GHA). This means their haematology units are specifically vetted for international patient support. Their clinical ties with Harvard University provide access to the latest global research protocols. This oversight helps streamline the transition from intensive Athenian care to monitoring in Australia.

Patient Consensus: Patients in Greece note that transfusions offer quick symptom relief. However, they emphasise that a durable response takes months of patience. They suggest confirming whether your team defines success as rising counts or total remission.

Are new drugs or clinical trials available for Aplastic Anaemia treatment in Greece?

Patients in Greece can access new drug protocols and clinical trials for aplastic anaemia. Treatment includes horse antithymocyte globulin (hATG) and Eltrombopag. Greek hospitals participate in EU-wide research programmes. Leading centres in Thessaloniki manage bone marrow failure cases through intensive haematology units.

  • Drug therapies: Centres use Eltrombopag to boost blood cell production in severe cases.
  • Clinical trials: Access is provided through the EU Clinical Trials Information System (CTIS).
  • Transplants: Specialist units perform haploidentical stem cell transplants for refractory cases.
  • Research links: Interbalkan European Medical Center cooperates with Massachusetts General Hospital (USA).

Bookimed Expert Insight: Greek haematology centres often share research protocols with top-tier American institutions. Interbalkan European Medical Center maintains a direct partnership with Harvard University and Massachusetts General Hospital. This connection allows local clinicians to use international best practices for rare bone marrow disorders.

Patient Consensus: Patients note that finding a centre with a dedicated haematology unit is essential. They recommend confirming how Greek doctors will manage blood monitoring after returning to Australia. Confirming experience with horse-derived antithymocyte globulin (hATG) is a priority during initial discussions.

無料相談を受ける

最適な連絡方法をお選びください